Posts by admin

On one wall in the modest office of Maria Gomes-Solecki, DVM, a professor in the Department of Microbiology, Immunology & Biochemistry at the University of Tennessee Health Science Center, hangs a framed letter that is the culmination of more than 20 years of work. Dated April 27, the letter is from the U.S. Department of…

According to the Centers for Disease Control, as many as 476,000 people in the U.S. contract Lyme disease every year. Climate change and human encroachment into wilderness areas means ticks and the disease-causing bacteria they carry are becoming more common. Dr. Linden Hu, an immunology professor and co-director of the Lyme Disease Initiative at Tufts…

The US Department of Agriculture (USDA) has conditionally licensed an oral vaccine designed to limit the spread of Borrelia burgdorferi, the bacterium that causes Lyme disease. The vaccine is sprayed onto pellets and distributed in natural settings to be consumed by mice. Lyme disease is the nation’s most common vectorborne disease, and the US Centers…

MEMPHIS (Precision Vaccinations) The U.S. Department of Agriculture recently issued a Conditional Licensure for a novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease. Announced by US Biologic, Inc. on May 9, 2023, this innovative Borrelia Burgdorferi Bacterin vaccine is spray-coated onto pellets that mice consume. As the expression goes, if you give a mouse a vaccine…..…

MEMPHIS, Tenn. – US Biologic, a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announces USDA Conditional Licensure of its novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, the number one vector-borne disease in the U.S. The only known vector is the…

Let’s begin with a blacklegged tick. At the risk of anthropomorphizing, we’ll call him Hank. A fledgling tick, Hank is a larva, and to move into the next stage of his life cycle, a nymph, he needs a meal — specifically, a blood meal. So, young Hank, ever determined, latches on to a white-footed mouse —…

Dr. Jolieke G. van Oosterwijk, US Biologic Chief Scientific Officer, presented key findings on a chewable flu vaccine that US Biologic is developing in partnership with the Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation, and Ventures (DRIVe) as part of its Beyond the Needle program. The presentation was held at the…

Host Jeremy C. Park talks with Dr. Jolieke van Oosterwijk, Chief Scientific Officer with US Biologic, who highlights the Memphis-based company developing groundbreaking orally delivered vaccines, changing global disease prevention and allowing safe, effective, and cost-efficient delivery of preventative interventions to wildlife, companion animals, food animals, and humans. During the interview, Jolieke discusses how they…

US Biologic’s CSO, Dr. Jolieke G. van Oosterwijk, presented at the World Vaccine Congress in Washington, D.C. Dr. van Oosterwijk discussed “using zoonotic disease surveillance to guide oral vaccine design” and presented the methods US Biologic uses to prevent pandemic-level diseases. In her talk, Dr. van Oosterwijk explained to the audience the unique nature of oral…